课题基金 / 基金详情

Molecular Mechanisms of Arterigenesis

Molecular Mechanisms of Arterigenesis
动脉发生的分子机制
批准号:
10192382
负责人:
Michael Simons
金额:
$191.79万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-02-10 至 2023-05-31

项目摘要

项目成果

Michael Simons的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The overall goal of this Program Project is to understand molecular mechanisms regulating arteriogenesis that may be exploited as potential treatments for vasoocclusive cardiovascular diseases including coronary artery disease, peripheral arterial disease and cerebrovascular disease. We have assembled a multidisciplinary team of highly accomplished PIs with diverse backgrounds (cardiology, cell biology, biomechanical engineering, pharmacology) to investigate key molecular events that lead to development and growth of arterial vasculature. The in-depth understanding of these mechanisms can then be parlayed into development of novel therapeutic modalities for this important group of cardiovascular diseases. Together, our studies will define the key events leading to arterial vessel growth and will lead to the development of new therapies. PPG Aims are: Aim 1. Elucidate how ERK signaling controls arteriogenesis (Project 1). Aim 2. Unravel the role of the miR 17-92 cluster in controlling arteriogenesis and its regulation and interaction with ERK signaling (Project 2 Aim 3. Determine how fluid shear stress and changes in the extracellular matrix activate ERKs and other signaling pathways that mediate arteriogenesis, and identify restriction points that impair arteriogenesis in disease (Project 3). Relevance to Public Health: Coronary artery disease and peripheral artery disease are major causes of illness and death in developed nations. Poor arteriogenesis is a critical determinant of these diseases and in patients’ recovery after myocardial infarction. This application proposes to elucidate the signaling network that governs flow-dependent vessel remodeling and test two new directions for improving arteriogenesis. These studies include testing whether activating an arteriogenic signaling pathway improves arteriogenesis in disease models. They have the potential to identify new targets and new reagents for therapy, as well as to achieve a deeper understanding of the fundamental biology that will form the basis for future studies.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ischemia/Reperfusion injury and Myocardial edema
  • 批准号:
    10718260
  • 项目类别:
  • 资助金额:
    $61.03万
  • 财政年份:
    2023
  • 负责人:
    Michael Simons
  • 依托单位:
Vascular smooth muscle cell heterogeneity and disease
  • 批准号:
    10356855
  • 项目类别:
  • 资助金额:
    $83.06万
  • 财政年份:
    2021
  • 负责人:
    Michael Simons
  • 依托单位:
Vascular smooth muscle cell heterogeneity and disease
  • 批准号:
    10559596
  • 项目类别:
  • 资助金额:
    $83.11万
  • 财政年份:
    2021
  • 负责人:
    Michael Simons
  • 依托单位:
ERK signaling in arteriogenesis
  • 批准号:
    10433818
  • 项目类别:
  • 资助金额:
    $56.25万
  • 财政年份:
    2012
  • 负责人:
    Michael Simons
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: